Gara Jalqabaatti › Myelodysplastic Syndromes › New York

Qorannoo klinikaalii Myelodysplastic Syndromes New York keessatti

Qorannoo 38 Myelodysplastic Syndromes f New York keessatti hirmaatuu jiru.

Magaalota New York keessatti

Takkalaa qorannoo (Ingiliffa)

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

Roswell Park Cancer Institute, Buffalo
Memorial Sloan Kettering Commack, Commack
Northwell Health/Center for Advanced Medicine, Lake Success
fi 9 dabalataa

Namoota walitti qabaa jiraSadarkaa 2

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT05564390

Testing the Addition of an IDH2 Inhibitor, Enasidenib, to Usual Treatment (Cedazuridine-Decitabine) for Higher-Risk Myelodysplastic Syndrome (MDS) With IDH2 Mutation (A MyeloMATCH Treatment Trial)

Roswell Park Cancer Institute, Buffalo
Stony Brook University Medical Center, Stony Brook

Namoota walitti qabaa jiraSadarkaa 2

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT06577441

Testing the Anti-cancer Drug, Cirtuvivint, and Its Combination With ASTX727 to Improve Outcomes in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndromes

Memorial Sloan Kettering Commack, Commack
Memorial Sloan Kettering Westchester, Harrison
Memorial Sloan Kettering Cancer Center, New York
fi 1 dabalataa

Namoota walitti qabaa jiraSadarkaa 1

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 01-Onk-2026 · NCT06484062

A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies

Memorial Sloan Kettering Cancer Center, New York

Namoota walitti qabaa jiraSadarkaa 1

Umuriin 12 hanga 78 · Saalaa hunda · Haaromfame 29-Ful-2026 · NCT03802695

Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia

Memorial Sloan Kettering Cancer Center, New York
Icahn School of Medicine at Mount Sinai, New York
Montefiore, New York

Namoota walitti qabaa jiraSadarkaa 1/2

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 23-Ful-2026 · NCT05320198

A Study to Compare Elritercept With Epoetin Alfa to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions

Hematology Oncology Associates of Rockland, Nyack
Albert Einstein College - Montefiore, The Bronx

Namoota walitti qabaa jiraSadarkaa 3

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 18-Ful-2026 · NCT07422480

Collection of Tissue Samples for Cancer Research

Roswell Park Cancer Institute, Buffalo

Namoota walitti qabaa jiraQorannoo ilaalaa

2 Months · Saalaa hunda · Haaromfame 16-Ful-2026 · NCT00900198

A Telehealth Advance Care Planning Intervention

University of Rochester, Rochester

Namoota walitti qabaa jira

Umuriin 60 fi ol · Saalaa hunda · Haaromfame 11-Ful-2026 · NCT05875805

Cord Blood Transplant in Adults With Blood Cancers

Memorial Sloan Kettering Cancer Center, New York

Namoota walitti qabaa jiraSadarkaa 2

Umuriin 21 hanga 65 · Saalaa hunda · Haaromfame 11-Ful-2026 · NCT05884333

Ivosidenib (IVO) Monotherapy and Azacitidine (AZA) Monotherapy in Patients With Hypomethylating Agent (HMA) Naive Myelodysplastic Syndromes (MDS) With an IDH1 Mutation

MSKCC, New York

Namoota walitti qabaa jiraSadarkaa 3

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 03-Ful-2026 · NCT06465953

The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

Albany Medical Center, Albany
Maimonides Medical Center, Brooklyn
NYU Langone Hospital - Long Island, Mineola
fi 7 dabalataa

Namoota walitti qabaa jiraSadarkaa 1/2

Hanga umuriin 22 · Saalaa hunda · Haaromfame 25-Hag-2026 · NCT04726241

A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions

Northwell Health, Lake Success
Clinical Research Alliance NY, Westbury

Namoota walitti qabaa jiraSadarkaa 3

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 21-Hag-2026 · NCT06499285

A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS)

New York Cancer and Blood, Shirley

Namoota walitti qabaa jiraSadarkaa 2

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 21-Hag-2026 · NCT04419649

ICP-248 in Combination With Azacitidine for the Treatment in Patients With Myeloid Malignancies

NYU Langone Health, New York

Namoota walitti qabaa jiraSadarkaa 1

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 18-Hag-2026 · NCT06656494

Study of R289 in Patients With Lower-risk Myelodysplastic Syndromes (LR MDS)

Ichan School of Medicine at Mount Sinai, New York

Namoota walitti qabaa jiraSadarkaa 1/2

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 10-Hag-2026 · NCT05308264

Study of AZD3632 Monotherapy or in Combination With Anticancer Agents in Participants With Advanced Haematologic Malignancies With KMT2Ar, NPM1m, or Other Genotypes Associated With HOX Overexpression

Research Site, New York

Namoota walitti qabaa jiraSadarkaa 1/2

Umuriin 16 fi ol · Saalaa hunda · Haaromfame 20-Ado-2026 · NCT07155226

Genomically Profiling, Collecting, Archiving and Distributing Hematologic Malignancy Specimens

Albany Medical Center, Albany

Namoota walitti qabaa jiraQorannoo ilaalaa

Hanga umuriin 30 · Saalaa hunda · Haaromfame 16-Ado-2026 · NCT04968834

Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome

Weill Cornell Medicine - New York Presbyterian Hospital, New York

Namoota walitti qabaa jiraSadarkaa 2

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 07-Ado-2026 · NCT07216443

Hyperbaric Oxygen Therapy and Allogeneic Peripheral Blood Stem Cell (PBSC) Transplant

Wilmot Cancer Institute, University of Rochester, Rochester

Namoota walitti qabaa jiraSadarkaa jalqabaa 1

Umuriin 18 hanga 75 · Saalaa hunda · Haaromfame 03-Wax-2026 · NCT03964506

Cord Blood Transplantation in Children and Young Adults With Blood Cancer

Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York

Namoota walitti qabaa jiraSadarkaa 2

Hanga umuriin 26 · Saalaa hunda · Haaromfame 14-Cam-2026 · NCT07566377

A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)

Roswell Park Comprehensive Cancer Center, Buffalo
New York University Langone Hospital - Long Island, Mineola
Perlmutter Cancer Center - 34th Street, New York
fi 2 dabalataa

Namoota walitti qabaa jiraSadarkaa 2/3

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 30-Elb-2026 · NCT04256317

A Study of GLB-001 in Patients With Relapsed or Refractory Acute Myeloid Leukemia or Relapsed or Refractory Higher Risk Myelodysplastic Syndromes

Icahn School of Medicine at Mount Sinai, New York

Namoota walitti qabaa jiraSadarkaa 1

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 13-Elb-2026 · NCT06146257

A Study of CTX-712 in Relapsed/Refractory Acute Myeloid Leukemia and Higher Risk Myelodysplastic Syndromes

The University of Rochester, Rochester

Namoota walitti qabaa jiraSadarkaa 1/2

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 13-Elb-2026 · NCT05732103

Safety and Proof-of-Concept Study of RPT1G in Adults With Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndromes

Memorial Sloan Kettering Cancer Center, New York

Namoota walitti qabaa jiraSadarkaa 1

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Bit-2026 · NCT07107126

A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)

Roswell Park Comprehensive Cancer Center, Buffalo

Namoota walitti qabaa jiraSadarkaa 1/2

Umuriin 12 fi ol · Saalaa hunda · Haaromfame 24-Bit-2026 · NCT04988555

FHD-286 With Low-Dose Weekly Decitabine/Venetoclax in Patients With Acute Myeloid Leukemia

Montefiore Medical Center, The Bronx

Namoota walitti qabaa jiraSadarkaa 1

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 03-Bit-2026 · NCT07283094

CLN-049 in Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)

Roswell Park Cancer Institute, Buffalo
New York University, New York

Namoota walitti qabaa jiraSadarkaa 1

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 16-Ama-2026 · NCT05143996

Venetoclax Plus Intensive Chemotherapy in AML and Advanced MDS

Montefiore Einstein Cancer Center and Children's Hospital at Montefiore (CHAM), The Bronx

Namoota walitti qabaa jiraSadarkaa 1

Umuriin 18 hanga 75 · Saalaa hunda · Haaromfame 08-Ama-2026 · NCT05342584

Metabolically Optimized, Non-cytotoxic Low Dose Weekly Decitabine/Venetoclax in MDS and AML

Montefiore Medical Center, The Bronx
White Plains Hospital, White Plains

Namoota walitti qabaa jiraSadarkaa 2

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 05-Ama-2026 · NCT05184842

Study of SX-682 Alone and in Combination With Oral or Intravenous Decitabine in Subjects With Myelodysplastic Syndrome

Montefiore Medical Center, The Bronx

Namoota walitti qabaa jiraSadarkaa 1

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 23-Mud-2025 · NCT04245397

Danvatirsen Monotherapy Followed by Combination With Venetoclax in Relapsed/Refractory MDS & AML

Montefiore Medical Center, The Bronx

Namoota walitti qabaa jiraSadarkaa 1Hojjettoota fayyaa simatamoo

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 10-Sad-2025 · NCT05986240

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Massive Bio SYNERGY-AI site, Buffalo
Massive Bio SYNERGY-AI site, Hempstead
Massive Bio SYNERGY-AI site, Manhasset
fi 2 dabalataa

Namoota walitti qabaa jiraQorannoo ilaalaa

Umuriin hundi · Saalaa hunda · Haaromfame 28-Onk-2025 · NCT03452774

Umbilical Cord Blood Transplantation From Unrelated Donors

Wilmot Cancer Institute, Rochester

Namoota walitti qabaa jiraQorannoo ilaalaa

2 Months – 75 Years · Saalaa hunda · Haaromfame 10-Onk-2025 · NCT03016806

A Study of BH-30236 in Relapsed/ Refractory Acute Myelogenous Leukemia and Higher Risk Myelodysplastic Syndrome

Roswell Park Cancer Institute, Buffalo
Memorial Sloan Kettering Cancer Center, New York

Namoota walitti qabaa jiraSadarkaa 1

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 24-Ful-2025 · NCT06501196

Monitoring Minimal Residual Disease of Patients With Acute Myelogenous Leukemia or High Grade Myelodysplastic Syndrome

University of Rochester Medical Center, Rochester

Namoota walitti qabaa jiraQorannoo ilaalaa

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 17-Ful-2025 · NCT01311258

Study of REM-422 in Patients With AML or Higher Risk MDS

Memorial Sloan Kettering, New York

Namoota walitti qabaa jiraSadarkaa 1

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 23-Elb-2025 · NCT06297941

Prevention of GvHD in Participants With Hematological Malignancies Undergoing Hematopoietic Stem Cell Transplant (HSCT)

Memorial Sloan Kettering Cancer Center, New York

Namoota walitti qabaa jiraSadarkaa 1

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 15-Elb-2025 · NCT06462365

A Study of BTX-A51 in People With Relapsed or Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome

Memorial Sloan-Kettering Cancer Center, New York

Namoota walitti qabaa jiraSadarkaa 1

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 20-Bit-2024 · NCT04243785

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.